Skip to content

Wednesday, May 1, 2024

Latest:

Wearable technology gives surgeons data to improve posture during surgery
Uncovering the secret of long-lived stem cells
Headed to a festival or outdoor event soon? Here is what you should know
Healthcare on wheels: Using mobile clinics to reach children all over Houston
Research method finds new use in diagnosis of genetic disorders

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CAR Tcells

From The Labs

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

January 19, 2024 cancer therapy, CAR Tcells, CD5, clinical trial, Research, T cell lymphoma

A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.

From the Labs Image of the Month:

From the Labs: Human retinal organoid.